AcquisitionOther
Dicerna Pharmaceuticals Inc acquired Dicerna
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Dicerna Pharmaceuticals Inc -> Dicerna · $38.25
Novo Nordisk and Dicerna have been parties to a research collaboration since 2019 to discover and develop RNAi therapies using Dicernas proprietary GalXC RNAi platform technology.
Open source record (SEC) ↗